Harrow (HROW) Current Deferred Tax Assets (2013 - 2014)
Harrow (HROW) recorded quarterly Current Deferred Tax Assets of $30000.0 in Q4 2014, down 25.0% quarter-over-quarter from $40000.0 in Q4 2013, and down 25.0% on a YoY basis from $40000.0 in Q4 2013.
Harrow (HROW) Current Deferred Tax Assets (2013 - 2014) Analysis & Trends
Harrow's Current Deferred Tax Assets history runs 2 years deep, the most recent figure standing at $30000.0 for Q4 2014.
- In Q4 2014, Current Deferred Tax Assets fell 25.0% year-over-year to $30000.0; the TTM figure through Dec 2014 stood at $30000.0 (down 25.0% YoY), while the FY2014 annual figure was $30000.0, down 25.0% from the prior year.
- Current Deferred Tax Assets was $30000.0 for Q4 2014 at Harrow, down from $40000.0 in the prior quarter.
- In the past five years, Current Deferred Tax Assets ranged from a high of $40000.0 in Q4 2013 to a low of $30000.0 in Q4 2014.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | Harrow | 1.25 Bn | 1.15 Bn | 27.05 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2014 | 30,000.00 |
| Dec 31, 2014 | 30,000.00 |
| Dec 31, 2013 | 40,000.00 |
| Dec 31, 2013 | 40,000.00 |